The current role of neoadjuvant chemotherapy in the management of cervical carcinoma

Gynecologic Oncology

Volumn 110, Issue 3 SUPPL.2, 2008, Pages

  González Martín, Antonio ^a,b   González Cortijo, Lucía ^a   Carballo, Natalia ^a   Garcia, Juan F ^a   Lapuente, Fernando ^a   Rojo, Alejandro ^a   Chiva, Luis M ^a  

^a MD ANDERSON CANCER CENTER   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Cervical carcinoma; Chemotherapy; Meta analysis; Neoadjuvant chemotherapy

Indexed keywords

CISPLATIN; EPIRUBICIN; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PACLITAXEL; TOPOTECAN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; META ANALYSIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; SYSTEMATIC REVIEW; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; NEOADJUVANT THERAPY; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 50049106017     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.012     Document Type: Article

References (19)

1. WHO. World Health Organization Report: Comprehensive Cervical Cancer Control: a Guide to Essential Practice. World Health Organization Web site (2006). http://www.who.int/reproductive-health/publications/cervical_cancer_gep/index.htm Available at: www.who.int/reproductive-health/publications/cervical_cancer_gep/index.htm. Accessed on February 2008.
2. Parkin M., and Bray F. The burden of HPV-related cancers. Vaccine 24 suppl 3 (2006) S11-S25
3. Benedetti Panici P., Greggi S., Scambia G., et al. Long term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 34 (1998) 341-346
4. Buda A., Fossati R., Colombo N., et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adiuvante Portio) Italian Collaborative Study. J Clin Oncol 23 (2005) 4137-4145
5. Ryu H.S., Kang S.B., Kim K.T., et al. Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005). Int J Gynecol Cancer 17 (2007) 132-136
6. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Metaanalysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39 (2003) 2470-2486
7. Benedetti-Panici P., Greggi S., Colombo A., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced cervical cancer: results from the Italian multicenter randomised study. J Clin Oncol 20 (2002) 179-188
8. Eddy G., Bundy B., Creasman W., et al. Treatment of "bulky" stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 106 (2007) 362-369
9. Omura G.A., Blessing J.A., Vacarello L., et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 15 (1997) 165-171
10. Moore D.H., Blessing J.A., McQuellon M.P., et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22 (2004) 3113-3119
11. Long III H.J., Bundy B.N., Grendys Jr. E.C., et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 23 (2005) 4626-4633
12. Monk B., Huang H.Q., Cella D., et al. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23 (2005) 4617-4625
13. Dueñas-González A., López-Graniel C., González-Enciso A., et al. Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Ann Oncol 13 (2002) 1212-1219
14. Park D.C., Kim J.H., Lew Y.O., et al. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92 (2004) 59-63
15. Dueñas-González A., López-Graniel C., González-Enciso A., et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 14 (2003) 1278-1284
16. D'Agostino G., Distefano M., Greggi S., et al. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer Chemother Pharmacol 49 (2002) 256-260
17. Zanetta G., Lissoni A., Pellegrino A., et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 9 (1998) 977-980
18. Di Vagno G., Cormio G., Pignata S., et al. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer 13 (2003) 308-312
19. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786